EPISODE · May 19, 2026 · 7 MIN
SHTG Digest — Tuesday May 19, 2026
from SHTG Daily Digest — Weiss Lab
A landmark Circulation imaging trial shows olezarsen dramatically lowers triglycerides but does not shrink coronary plaque, while two new meta-analyses confirm robust TG and pancreatitis benefits across the ApoC-III inhibitor class, and on the industry side both Arrowhead and Ionis are sprinting toward a mid-2026 collision in the sHTG market.
Embed this episode
NOW PLAYING
SHTG Digest — Tuesday May 19, 2026
0:00
7:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of SHTG Daily Digest — Weiss Lab?
This episode is 7 minutes long.
When was this SHTG Daily Digest — Weiss Lab episode published?
This episode was published on May 19, 2026.
Can I download this SHTG Daily Digest — Weiss Lab episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!